Medrobotics Stock

Medrobotics Corporation is a medical robotics company developing and commercializing the Flex Robotic System.

Sign up today and learn more about Medrobotics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Medrobotics Stock

Medrobotics Corporation (formerly Cardioborobotics, Inc.) is a Delaware "C" Corporation, originally formed in 2005 (as Innovention Technologies, LLC) by the inventors of our technology. They are Howie Choset, PhD, a tenured Associate Professor of Robotics at Carnegie Mellon University, Dr. Marco Zenati, a cardiothoracic surgeon and Visiting Professor of Surgery at Harvard Medical School, and Dr. Alon Wolf, Associate Professor at Technion University in Israel. Dr. Zenati was on the medical faculty of the University of Pittsburgh at the time he and Drs. Choset and Wolf developed the first generation medical "snake robotics" platform in-licensed by the Company. Dr. Choset and Dr. Zenati continue to remain involved in technology development at the Company. Medrobotics has exclusive worldwide licenses for its technologies from Carnegie Mellon University and the University of Pittsburgh as well as additional robust development of its own intellectual property portfolio. The Company has an operational facility in New England, with partners located throughout the United States.

Funding History

February 2011$6.5M
May 2011$3.6M
November 2011$11.7M
August 2012$8.0M
December 2012$33.6M
March 2013$10.0M
May 2014$26.0M
October 2014$20.0M
November 2015$25.0M
January 2017$20.0M

Management

Vice President, Global Sales

Richard Walsh

Chief Financial Officer & Treasurer

Mark Peters

Vice President, Clinical, Regulatory & Quality Affairs

John Bonasera

Vice President, Intellectual Property Strategy

Christopher Flaherty

Co-Founder

Howie Choset

Chairman of the Board of Directors

James Jordan

Vice President of Operations

Michael Gallagher

Founder

Alon Wolf

Vice President, Marketing

Thomas Patzelt

President & CEO

Samuel Straface

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo